Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Mouse ES cell–derived cardiac precursor cells are multipotent and facilitate identification of novel cardiac genes
Nicolas Christoforou, … , Andrew S. McCallion, John D. Gearhart
Nicolas Christoforou, … , Andrew S. McCallion, John D. Gearhart
Published February 1, 2008
Citation Information: J Clin Invest. 2008;118(3):894-903. https://doi.org/10.1172/JCI33942.
View: Text | PDF
Research Article Cardiology

Mouse ES cell–derived cardiac precursor cells are multipotent and facilitate identification of novel cardiac genes

  • Text
  • PDF
Abstract

Although the differentiation of ES cells to cardiomyocytes has been firmly established, the extent to which corresponding cardiac precursor cells can contribute to other cardiac populations remains unclear. To determine the molecular and cellular characteristics of cardiac-fated populations derived from mouse ES (mES) cells, we isolated cardiac progenitor cells (CPCs) from differentiating mES cell cultures by using a reporter cell line that expresses GFP under the control of a cardiac-specific enhancer element of Nkx2-5, a transcription factor expressed early in cardiac development. This ES cell–derived CPC population initially expressed genetic markers of both stem cells and mesoderm, while differentiated CPCs displayed markers of 3 distinct cell lineages (cardiomyocytes, vascular smooth muscle cells, and endothelial cells) — Flk1 (also known as Kdr), c-Kit, and Nkx2-5, but not Brachyury — and subsequently expressed Isl1. Clonally derived CPCs also demonstrated this multipotent phenotype. By transcription profiling of CPCs, we found that mES cell–derived CPCs displayed a transcriptional signature that paralleled in vivo cardiac development. Additionally, these studies suggested the involvement of genes that we believe were previously unknown to play a role in cardiac development. Taken together, our data demonstrate that ES cell–derived CPCs comprise a multipotent precursor population capable of populating multiple cardiac lineages and suggest that ES cell differentiation is a valid model for studying development of multiple cardiac-fated tissues.

Authors

Nicolas Christoforou, Ronald A. Miller, Christine M. Hill, Chunfa C. Jie, Andrew S. McCallion, John D. Gearhart

×

Figure 4

Differentiation capacity and differentiation efficiency of mES cell–derived CPCs.

Options: View larger image (or click on image) Download as PowerPoint
Differentiation capacity and differentiation efficiency of mES cell–deri...
FACS-sorted CPCs were cultured for 7 days in high serum culture medium (condition I), no serum culture medium (condition II), or high serum culture medium plus VEGF (condition III). (A) RT-PCR analysis on RNA isolated from FAC sorted and differentiated CPCs. Transcripts analyzed included cardiac markers Nkx2-5, Isl1, Flk1, Myocd, Mef2c, Gata4, Myl4, and Tnnt2; smooth muscle markers Acta2 and Myh11; endothelial marker Cdh5; stem cell markers Kit and Nanog; skeletal muscle marker Myod1; hepatic marker Afp; and the positive control marker Gapdh. Temporally matched FACS-sorted and differentiated GFP– mES cells expressed high levels of ES cell markers Pou5f1 (not shown) and Nanog. (B) Efficiency of GFP+ CPC and GFP– cell differentiation into cardiomyocytes (Actn1), smooth muscle cells (Acta2), and endothelial cells (Cd31) as assayed by FACS analysis.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts